US Patent Issued to Genentech on Oct. 6 for "Compositions and methods of treating lupus nephritis" (California Inventor)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,005, issued on Oct. 6, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Compositions and methods of treating lupus nephritis" was invented by Paul Brunetta (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides methods for treating or delaying progression of lupus nephritis in an individual that has lupus. In some embodiments, the methods comprise administering to the individual an effective amount of a type II anti-CD20 antibody. The invention also provides methods for treating or delaying progression of rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) in an individual. In some embodiments, ...